Congrats to Angelo and team on their recent publication which describes a microfluidic-based biomaterial encapsulation approach to improve the in vivo residence time of intravenously delivered MSCs - these modifications extended cell persistence even in the presence of innate and adaptive immunity-mediated clearance. Check it out here: Programmable microencapsulation for enhanced mesenchymal stem cell persistence and immunomodulation